MedAvail to Present at the 39th Annual J.P. Morgan Healthcare Conference

Jan. 6, 2021 13:00 UTC

 

 
 

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)-- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company driving best in class medication adherence by embedding its pharmacy services directly into Medicare focused clinics using its proprietary MedCenter solution, today announced that the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference.

MedAvail’s management is scheduled to present on Thursday, January 14, 2021 at 3:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at https://investors.medavail.com/.

About MedAvail

MedAvail Holdings Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

SOURCE MedAvail Holdings Inc.

Contacts

Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com

 
 

Source: MedAvail Holdings Inc.

Back to news